CLINICAL_TRIALS
trial_result
· 2023-01-23
Clinical Trial Update: Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS [Phase 2, Phase 3]
Summary
A phase 2/3 trial evaluating tacrolimus plus glucocorticoid for severe thrombocytopenia in Sjogren syndrome with other organ involvement is ongoing, with status…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Sjogren Syndrome With Other Organ Involvement | Phase 2, Phase 3 | Status: UNKNOWN